Healthcare
Wednesday, May 25, 2016
BRIEF-Txcell obtains authorization to restart Ovasave Phase IIb clinical trial
* Txcell obtains authorization from European regulatory authorities to restart Ovasave Phase
IIb clinical trial
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment